Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
University of Alabama at Birmingham, Birmingham, Alabama, United States
Nationwide Children's Hospital, Columbus, Ohio, United States
Golden Jubilee National Hospital, Clydebank, West Dunbartonshire, United Kingdom
Gentofte Hospital, Copenhagen, Denmark
Golden Jubilee National Hospital, Clydebank, West Dunbartonshire, United Kingdom
Golden Jubilee National Hospital, Clydebank, West Dunbartonshire, United Kingdom
KKH Dormagen, Dormagen, Germany
Bispebjerg Hospital, department of anesthesiology, Copenhagen, Denmark
CHU Clermont-Ferrand, Clermont-Ferrand, France
Department of anaesthesiology, Bispebjerg Hospital, Copenhagen, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.